Based on this evidence an independent clinical trial: “Effect of association between a cholinesterase inhibitor and α-GPC on cognitive deficits in AD associated with cerebrovascular impairment” (ASCOMALVA) was performed in Italy. The gene discussed is BCHE; the disease is Alzheimer disease.